Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients

Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post on LinkedIn:

“Finally published the study protocol of the ongoing prospective/retrospective study on the first-line therapy in mRCC patients!! 520 patients enrolled, but the number is progressively increasing!!

DOI: 10.1186/s12885-024-12319-1.”

Source: Sara Elena Rebuzzi/LinkedIn
.